Deal of the Day — limited-time pharmacy picks!
Telma ACT 40/5/6.25 mg Tablet

Telma ACT 40/5/6.25 mg Tablet

Prescription requiredRx Required

Salt Composition: Telmisartan (40mg) + Amlodipine (5mg) + Chlorthalidone (6.25mg)

Expiry Date: 01/2028

Special offer

Price on Request

Price on Request

Inclusive of all taxes

▼

15 Tablet

About The Product

Triple Combo For Maximum Bp Control

Description

Telma ACT 40/5/6.25mg tablet is an antihypertensive combination medicine. The medicine is used to treat high blood pressure (hypertension) in adults. Its contains three active ingredient is Telmisartan in (40mg) concentration, Amlodipine in (5mg) concentration and Chlorthalidone in (6.25mg) concentration.

They together work to lower the blood pressure effectively, decrease strain on the heart, and lower the risk of cardiovascular complications such as heart attack or stroke. Doctor's prescription is mandatory before using the tablet to avoid complications during the treatment.

​

Uses

  • Treats high blood pressure (Hypertension)


Side Effects

  • Telma ACT 40/5/6.25mg tablet cause several side effects that are easily manageable with certain treatment options.
  • If any of the following symptoms persist or worsen consult the healthcare professional instantly: • Fatigue (tiredness) • Bradycardia • Gastrointestinal disturbance • Electrolyte imbalance • The increased glucose level in the blood • Postural hypotension • Angioedema and urticaria • Visual disturbance • Breathlessness • Muscle cramp • Headache • Dizziness • Sleepiness • Ankle swelling​

How To Use

  • Doctor prescription is required while using Telma ACT 40/5/6.25mg tablet to ensure safe and effective treatment option.
  • The tablet should be taken with or without food at the same time every day to enhance the effectiveness, maintain consistent blood pressure and reduce the risk of side effects.
  • Do not crush, chew or break the tablet as it decrease the effectiveness of the medication and alter its absorption.​

How It Works

  • Telma ACT 40/5/6.25mg tablet contains three drugs that lowers blood pressure by Angiotensin-II (constricts vessels), inhibiting calcium entry into muscles (relaxes vessels), and reducing excess fluid/sodium. Telmisartan(40mg) acts as an angiotensin II receptor blocker (ARB) which preventing vasoconstriction and narrowing of blood vessels.
  • Amlodipine (5mg) is a calcium channel blocker that prevents calcium from entering vascular smooth muscle cells, causing blood vessels to relax and widen. Chlorthalidone (6.25mg) is a thiazide like diuretic that reducing fluid volume and improving blood flow.​​

Safety Advice

Alcohol
Consuming alcohol with Telma tablet is harmful. Doctor's prescription is mandatory before using the medicine.
Pregnancy
Pregnant women should avoid using Telma ACT 40/5/6.25mg tablet as it can affect the unborn baby.
Breast Feeding
Telma ACT 40/5/6.25mg tablet is passing through the breast milk which may harmful for the baby as well as mother. Discuss with the doctor about the dosage and duration correctly to avoid further complications during the treatment.
Driving
Telma tablet cause side effects like dizziness, weakness and decrease in eye vision. However, it is unsafe to use the medicine while driving. Consult the healthcare professional if the symptoms worsen.
Kidney
Telma ACT 40/5/6.25mg tablet is harmful or not, is not correctly administered. Follow the doctor's prescription before using the tablet.
Liver
Liver patient should avoid using Telma ACT tablet as it is not suitable with liver disease.

FAQs

Telma tablet is not administered to pregnant and breastfeeding women, kidney or liver patients and people with very low blood pressure.​

References

• McClellan, K. J., & Markham, A.

(1998). Telmisartan.

Drugs, 56(6). https://pubmed.ncbi.nlm.nih.gov/9878991/ • Sharpe, M., Jarvis, B., & Goa, K. L.

(2001). Telmisartan: a review of its use in hypertension.

Drugs, 61(10), 1501-1529. https://pubmed.ncbi.nlm.nih.gov/11558835/ • Wang, J. G., Palmer, B.

F., Vogel Anderson, K., & Sever, P. (2023).

Amlodipine in the current management of hypertension. The Journal of Clinical Hypertension, 25(9), 801-807. https://pubmed.ncbi.nlm.nih.gov/37551050/ • Şen, S., Demir, M., Yiğit, Z., & Üresin, A.

Y. (2018).

Efficacy and safety of s-amlodipine 2.5 and 5 mg/d in hypertensive patients who were treatment-naive or previously received antihypertensive monotherapy. Journal of Cardiovascular Pharmacology and Therapeutics, 23(4), 318-328. https://pubmed.ncbi.nlm.nih.gov/29649885/ • RAGHAVENDRA, R., Kota, R.

K., Setty, C. M., & PURUSHOTHAM, R.

(2009). Formulation and evaluation of fast dissolving chlorthalidone tablets.

International journal of pharmacy and pharmaceutical sciences, 1(1), 79-87. https://www.researchgate.net/publication/288455994_Formulation_and_evaluation_of_fast_dissolving_chlorthalidone_tablets​

i
Trust & safety

Medical Disclaimer

Accurate, reviewed information to support informed healthcare decisions

For informational purposes only
Not a substitute for professional medical advice
Consult your doctor for diagnosis and treatment

Magicine's primary objective is to ensure that its customers receive accurate, genuine, and trustworthy information reviewed by medical experts.

The content on this website has been produced solely for informational purposes. This is not intended to take the place of medical advice and care provided by a licensed professional, though.

This information may not include all potential side effects, warnings, and details about specific lab tests, medications, and medical conditions. Please ask your doctor any questions you may have about any drug or disease.

Our goal is not to replace or substitute for the doctor-patient relationship, but to uphold and strengthen it.

Always follow advice from your doctor, pharmacist, or other licensed healthcare professional before starting, stopping, or changing any medicine or treatment.
Read full medical disclaimer in Terms & Conditions
Magicine PharmacopyCopyright 2026